Bedolla-Gaxiola HA, Hernández-Molinar Y

Language: Spanish
References: 17
Page: 1609-1614
PDF size: 461.99 Kb.

ABSTRACT

Introduction: The oral manifestations associated with the Henoch-Schönlein purpura disease have not been specifically described or have been studied in depth side effects that cause the consumption of drugs to reduce the symptoms of this. Henoch-Schönlein purpura is the vasculitis that occurs mostly in children between two and six years, has a worldwide incidence between 10.5 and 20.4 cases per 100 thousand children per year. Clinical case: Male patient of nine years four months of age, with diagnosis of Henoch-Schönlein purpura, in the cephalometric analysis was obtained that the patient has a maxillomandibular-class relationship, face with brachifacial pattern, mandibular retrognathism, short cranial base, incipient biprotrusion, labial protrusion, horizontal growth pattern is evaluated by psychology with diagnoses of anxiety disorder and emotional retardation for their age. Odontopediatric treatment plan is made, generate space for eruption, redirect the growth process and placement of myofunctional appliances. Conclusion: The treatment should be multidisciplinary and from the focus of our specialty, it is important to implement strategies, which are focused on the prevention and installation of habits of oral hygiene, interdisciplinary communication is the integral basis to give a better quality of life to the patient.

REFERENCES

1. Camacho Lovillo MS, Lirola Cruz MJ. Púrpura de Shönlein-Henoch, enfermedad de Kawasaki y otras vasculitis. Pediatr Integr 2017; 21(3):183-95.

2. Willan R. Y P RÁCTICA Historia de la púrpura de Henoch-Schönlein. Acta Medica Colombiana 32(2): 97-100.

3. Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch-Schönlein): current state of knowledge. Curr Opin Rheumatol 2013; 25(2): 171-78.

4. McCarthy HJ, Tizard EJ. Clinical practice: Diagnosis and management of Henoch-Schönlein purpura. Eur J Pediatr. 2010;169(6): 643-50.

5. Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. LAncet 2002; 360(9341): 1197-202.

6. Cáceres-Mosquera DJ, Fuentes-Velasco DY, Romero-Navarro B. Púrpura de Henoch-Schönlein. Reporte de 105 pacientes pediátricos. Bol Med Hosp Infant Mex 2006; 63: 314-21.

7. Ma. Dolores López Saldaña. Púrpura de Schönlein-Henoch. Reumatología; 81-84.

8. Escoda Mora Jaume, et al. Púrpura de Schönlein- Henoch. A propósito de un caso en una deportista. Apunts. MEDICINA DE L’ESPORT 2017; 41(152): 151-54.

9. Jaulhola O. Henoch-Schönlein purpura in children. 2012.

10. Chen O, Xb Z, Ren P, Yb W, Rp S, De W. Henoch Schönlein Purpura in children : clinical analysis of 120 cases. 2013;13(1): 5-10.

11. Ricart Campos S. Púrpura de Schönlein-Henoch. Protoc diagn ter pediatr 2014; 1: 131-40.

12. Trnka P. Henoch-Schönlein purpura in children. J Paediatric Child Health 2013; 49(12): 995-1003.

13. Pan Y, Ye Q, Shao W, Shang S, Mao J, et al. Relationship between Immune Parameters and Organ Involvement in Children with Henoch-Schönlein Purpura. PLoS ONE 2014; 9(12): 1-12.

14. Tarvin SE, Ballinger S. Henoch-Schönlein purpura. Current Paediatrics 2006;16(4): 259-63.

15. Ceballos-Hernández H, et al. Tratamiento estomatológico interdisciplinario del lupus eritematoso generalizado. Acta pediatr. Mex 2015; 36(4): 330-36.

16. Kang Y, Park J, Ha Y, Kang M, Park H, Lee S, et al. Differences in Clinical Manifestations and Outcomes between Adult and Child Patients with Henoch-Schönlein Purpura. J Korean Med Sci 2014; 29(2): 198-203.

17. Gutiérrez J, Bagán J, Bascones A, Llamas R, Llena J, Morales A, et al. Documento de consenso sobre la utilización de profilaxis antibiótica en cirugía y procedimientos dentales. Av Odontoestomatol 2006; 22(1): 41-67.